At the time of writing, Legend Biotech Corp ADR [LEGN] stock is trading at $50.26, up 2.91%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The LEGN shares have gain 5.17% over the last week, with a monthly amount glided 1.03%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Legend Biotech Corp ADR [NASDAQ: LEGN] stock has seen the most recent analyst activity on October 08, 2024, when Redburn Atlantic initiated its Buy rating and assigned the stock a price target of $86. Previously, Truist started tracking the stock with Buy rating on June 17, 2024, and set its price target to $88. On May 24, 2024, H.C. Wainwright reiterated its Buy rating and revised its price target to $73 on the stock. Deutsche Bank started tracking the stock assigning a Buy rating and suggested a price target of $60 on May 23, 2024. Scotiabank upgraded its rating to a Sector Outperform but $65 remained the price target by the analyst firm on April 17, 2024. Cantor Fitzgerald started tracking with a Overweight rating for this stock on April 03, 2024, and assigned it a price target of $82. In a note dated March 13, 2024, Raymond James initiated an Outperform rating and provided a target price of $86 on this stock.
For the past year, the stock price of Legend Biotech Corp ADR fluctuated between $38.60 and $70.78. Currently, Wall Street analysts expect the stock to reach $79.5 within the next 12 months. Legend Biotech Corp ADR [NASDAQ: LEGN] shares were valued at $50.26 at the most recent close of the market. An investor can expect a potential return of 58.18% based on the average LEGN price forecast.
Analyzing the LEGN fundamentals
According to Legend Biotech Corp ADR [NASDAQ:LEGN], the company’s sales were 455.99M for trailing twelve months, which represents an 154.36% jump. Gross Profit Margin for this corporation currently stands at 0.57% with Operating Profit Margin at -0.76%, Pretax Profit Margin comes in at -0.63%, and Net Profit Margin reading is -0.63%. To continue investigating profitability, this company’s Return on Assets is posted at -0.16, Equity is -0.23 and Total Capital is -0.23. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.25.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 48.57 points at the first support level, and at 46.89 for the second support level. However, for the 1st resistance point, the stock is sitting at 51.27, and for the 2nd resistance point, it is at 52.29.
Ratios To Look Out For
It is important to note that Legend Biotech Corp ADR [NASDAQ:LEGN] has a current ratio of 4.84. In addition, the Quick Ratio stands at 4.78 and the Cash Ratio stands at 0.69. Considering the valuation of this stock, the price to sales ratio is 20.19, the price to book ratio is 7.94.
Transactions by insiders
Recent insider trading involved Huang Ying, Officer, that happened on Sep 25 ’24 when 1504.0 shares were purchased. Officer, Macomber Lori completed a deal on Sep 20 ’24 to buy 90060.0 shares. Meanwhile, Director Yau Wai Man Philip bought 1946.0 shares on Sep 20 ’24.
